DISCUSSION
Cellular proliferation of the biliary epithelium is facilitated by the regurgitation of pancreatic juice into the bile duct in patients with APBDU, and it caused genetic alterations in the bile duct. Repetitive regurgitation of pancreatic juice into the bile duct can induce a hyperplastic or dysplastic state in the biliary tract, potentially leading to cancerous changes in the mucosa [
910]. Previous studies have indicated that changes in the biliary mucosa also occur in patients with an anatomically normal pancreaticobiliary junction; this condition is called OPBR [
111213141516]. High biliary amylase levels can be observed in patients with OPBR; these are sometimes associated with biliary malignancies, similar to that noted in patients with APBDU [
111718].
With respect to APBDU and OPBR, there is a limitation regarding preoperative diagnosis; therefore, researchers are less interested in such studies. According to Itokawa et al. [
17], the bile juice amylase level in the gallbladder is equal to or higher than that in the common bile duct. Thus, the amylase level in the gallbladder may indicate OPBR, which would imply that the mechanism underlying APBDU also causes GBC.
However, the definition of OPBR is potentially controversial, and no cutoff values have been established. Itokawa et al. [
17] reported an OPBR frequency of 26% in patients with various pancreaticobiliary diseases, and the incidence of OPBR in patients with GBC was 36.0% (9 of 25), according to their OPBR definition. Beltrán et al. [
18] defined OPBR as a higher amylase level in the gallbladder than that in the serum and reported the incidence of OPBR as 84.2% in patients with benign gallbladder diseases and 100% in patients with GBC. In our study, OPBR was defined as a gallbladder amylase level more than 3 times higher than the serum amylase level, based on the definition for postoperative pancreatic fistulas.
The incidence of APBDU in patients with biliary disorders who underwent endoscopic retrograde cholangiography is 1.5% in Japan, 8.7% in Taiwan, and 1% in Europe. In the last decade, the incidence of APBDU-associated bile duct cancer in patients with and without biliary dilatation was 5.2% and 4.0%, respectively. Several studies have reported that biliary cancer is detected in 21.6% of adult patients with congenital biliary dilatation (bile duct cancer, 32.1%
vs. GBC, 62.3%) and in 42.4% of patients with pancreaticobiliary maljunction without biliary dilatation (bile duct cancer, 7.3%
vs. GBC, 88.1%) [
19202122]. In our previous study, we recommended that patients with high bile amylase levels after cholecystectomy should be carefully followed up for cholangiocarcinoma [
4]. However, there were no remarkable changes in these groups during the follow-up period. We speculated that this was because of the low incidence of bile duct cancer among patients with APBDU without bile duct dilatation. Additionally, the risk of bile duct cancer decreased after cholecystectomy; similar to a decrease in the risk of intrapancreatic bile duct cancer after choledochal cyst operation. However, the incidence of GBC in patients with APBDU without bile duct dilatation was high (88.1%) in our study, which could not be explained by pancreatic juice reflux alone. And we could not evaluate the presence of APBDU separately, so it was necessary to identify other clinicopathological factors related to GBC in patients with APBDU or OPBR without bile duct dilatation.
If OPBR presents with a functional problem related to the sphincter of Oddi, it may cause chronic bacterial infections owing to bile contamination caused by reflux from the duodenum into the biliary tract. Therefore, chronic bacterial infection in the bile has been suggested as a trigger for GBC. Several studies have reported that infection caused by specific organisms, such as
Salmonella typhi, is a leading cause of GBC [
5678]. The reported bacterial infection rate is 9%–42% during elective cholecystectomy, 35%–65% in the presence of symptomatic acute cholecystitis, and 30%–90% during biliary drainage treatment [
23]. In our study, the incidence of bacterial infection was 64%, which is higher than the 25.1% incidence during elective cholecystectomy for benign gallbladder disease reported in our previous study. In our present study, in the low amylase group, the positive culture rate was 50%. We could not identify exactly the reason for the positive culture rate in the low amylase group, but we can assume the possibilities of contamination. The patients with GB stone in the low amylase group were 56.3%. So we could guess the chronic inflammation with bacterial infection in these patients even if they had not OPBR. Bacterial infections were also more frequent in the high amylase group than in the low amylase group, indicating an association between OPBR and chronic bacterial infections (P = 0.048). Considering that OPBR can be a risk factor for GBC, we suggest a correlation between GBC and chronic bacterial infection in the gallbladder. Further, because the incidence of bile culture positivity was higher in patients with a high amylase level and in older patients, we hypothesize that alterations in the gallbladder mucosa due to chronic bacterial infections in patients with OPBR increase the risk of cancer.
In our study, the most commonly identified bacteria were E. coli, Klebsiella spp., and Enterococcus spp. (same as those detected during elective cholecystectomy). The frequency of gram-positive bacteria was higher in the high amylase group than in the low amylase group, but the difference was not significant. The role of prophylactic antibiotics in cancer surgery remains controversial. Antibiotic susceptibility studies have suggested that amikacin, ertapenem, imipenem, and trimethoprim/sulfamethoxazole are the most suitable antibiotics, but their use is limited in clinical applications. When considering antibiotic administration in the perioperative period, first- or second-generation cephalosporins should be avoided owing to their high rate of antimicrobial resistance.
This study has some limitations. The objective was to demonstrate the relationship between high bile amylase levels and chronic bacterial infections in patients with GBC. The study had a retrospective design and included only 25 patients with GBC. The degree of inflammation surrounding the cancer tissue was not evaluated, and the groups were not balanced according to the cancer stage. Furthermore, we could not determine the appropriate antibiotic treatment for patients because the bacterial status in the bile duct after surgery was not evaluated. The antimicrobial resistance of the isolated bacteria depends on several factors, including community differences and hospital antibiotic policies, and consequently, the antibiotic management should be adjusted considering these environmental factors.
However, chronic bacterial infections associated with OPBR may be correlated with GBC, and future studies, including biochemical and bacterial gallbladder bile fraction evaluation, are warranted for confirmation.
In patients with GBC, the clinicopathological factors did not differ according to the bile juice amylase levels. However, bacteria in gallbladder were identified more frequently when the amylase level was high. High amylase levels in the gallbladder can be associated with caused chronic bacterial infections with OPBR, potentially triggering GBC.
Go to :
